Reviewed by the PeptideMind Team · Updated July 15, 2026

Survodutide Dosage Guide, Benefits & Side Effects

This GLP-1/GCGR dual agonist cuts body weight up to 16.6% and resolves MASH in Phase 3 trials, while preserving lean muscle mass throughout treatment.

Chemical Makeup

16

Amino Acids

Survodutide

Ala

A

Position 1

Met

M

Position 2

Ile

I

Position 3

Asn

N

Position 4

Pyl

O

Position 5

Ala

A

Position 6

Cys

C

Position 7

Ile

I

Position 8

Asp

D

Position 9

Pro

P

Position 10

Glu

E

Position 11

Pro

P

Position 12

Thr

T

Position 13

Ile

I

Position 14

Asp

D

Position 15

Glu

E

Position 16

Amino acid sequence
AlaninePosition 1
MethioninePosition 2
IsoleucinePosition 3
AsparaginePosition 4
PyrrolysinePosition 5
AlaninePosition 6
CysteinePosition 7
IsoleucinePosition 8
Aspartic acidPosition 9
ProlinePosition 10
Glutamic acidPosition 11
ProlinePosition 12
ThreoninePosition 13
IsoleucinePosition 14
Aspartic acidPosition 15
Glutamic acidPosition 16

As seen on

American PressStreet InsiderBusiness InsiderBenzingaCBSYahoo Finance

Survodutide Dosage Guide for Weight Loss

Survodutide is an experimental weekly injection being studied for weight loss. It works by curbing appetite and boosting the number of calories your body burns, and early studies show it also helps with a liver condition called MASH.

Vial size

5 mg

Bacteriostatic water

2 mL

Dosing

1.2–4.8 mg

Frequency

Weekly

Cycle

12–24 weeks

Benefit

Weight Loss

Explore calculators

What is Survodutide?

Survodutide is a lab-made, injectable peptide that acts on two different hormone pathways at once to reduce appetite, slow digestion, and increase how many calories your body burns. It's being developed by a major pharmaceutical company and tested in late-stage trials for obesity, type 2 diabetes, fatty liver disease, and heart health outcomes.

Weight

Research targets include appetite regulation, fat metabolism, and body composition.

Metabolic

Research targets include glucose regulation, insulin sensitivity, and energy metabolism.

Weight

sur

Metabolic

Is Survodutide FDA approved?

Survodutide is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

Survodutide has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

A smartphone screen displaying FDA status for a drug, indicating "FDA approved drug: No" and "Classification: Research use only." A banner notes "Research Only" with the disclaimer "not for human use," emphasizing its intended use for laboratory and analytical purposes.

Our top-rated vendor

View all

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health logo

Protide Health

#1 Rated Research Peptide Supplier

How Does Survodutide Work?

It activates two separate hormone receptors at once: one slows digestion and curbs appetite, while the other tells the liver to break down fat and raises the number of calories the body burns. Combining both effects tends to produce more weight loss than targeting just one of these pathways alone.

Two receptors at once

Activates two separate hormone receptors simultaneously.

Curbs appetite

One slows digestion and curbs appetite.

Burns fat

The other tells the liver to break down fat and raises calorie burn.

Survodutide Targeted areas

How to reconstitute Survodutide

View guide

The materials you'll need and step-by-step instructions for safely mixing Survodutide with bacteriostatic water.

Materials needed

Your Survodutide vial (lyophilized)

Alcohol swabs

Bacteriostatic sterile water

3 mL syringes (Luer Lock tip)

25G or 27G needles (Luer Lock). Other gauges may also be acceptable.

Sharps container (optional)

1

Remove the caps

Remove the caps from both your Survodutide vial and your bacteriostatic water vial.
2

Sanitize the rubber stoppers

Wipe down the rubber stoppers on both vials with alcohol swabs and let them dry for about 3 minutes.
3

Attach the needle

Take your 3 mL syringe and needle. Twist the needle's plastic hub into the Luer Lock tip on the syringe to secure it.
4

Draw the bac water

Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.

How much bac water? Survodutide typically comes in a 5 mg vial. We recommend 2 mL of bacteriostatic water, though anywhere between 1 mL and 3 mL is acceptable. For larger vials you can use up to 5 mL — more bac water makes microdosing easier, but insulin needles usually max out at 1 mL per injection. That means a lot of bac water might force you into multiple injections to hit your target dose. Unless you're microdosing, 2 mL per vial is a solid rule of thumb.
5

Insert the needle into the Survodutide vial

With the bac water in your syringe, insert the needle into the Survodutide vial at a slight angle to avoid pressure buildup.

Use a thin needle: Stick to 25G or higher to avoid damaging the rubber stopper. Higher gauge means a thinner needle.
6

Release the water gently

Let the water run gently down the side of the vial. Don't inject it forcefully.

Heads up: Sometimes the plunger pushes itself in as soon as the needle enters the vial. Hold the plunger back so you have full control over how fast the bac water enters.
7

Swirl to dissolve

Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.

Be patient: This usually takes 2 to 5 minutes of consistent swirling, mixing in a circular motion, and gently flipping the vial up and down. The water needs to run through the powder many times to fully dissolve it. Don't shake or get aggressive with it.
8

Check for full dissolution

The solution should be clear with no visible particles. If it's cloudy or clumpy, wait a minute and repeat the swirling step.
9

Cap, dispose, and store

Once you're done, cap the needle and dispose of it (ideally in a sharps container). Store the reconstituted Survodutide vial in the fridge whenever it's not in use. It will stay good for approximately 30 days.

How to Store Survodutide

Freeze the dry powder for up to three years, or refrigerate it for up to two. Once mixed with bacteriostatic water, refrigerate and use within about a month — don't shake it, and keep it away from light.

Lyophilized Storage

-20°C for up to 3 years, or 4°C for up to 2 years.

Reconstituted Storage

In bacteriostatic water, 2–8°C, use within 28 days.

Handling Notes

Do not shake; store away from light.

A smartphone displaying a "Storage Guide" for peptides, indicating a safe storage temperature range of 2–8°C, with warnings to keep away from light, heat, and freezing. The background is light blue, and additional tips on protecting the peptides are visible below the temperature range.

What Are the Benefits of Survodutide?

What research says it may help with, and how it works in the body.

weight loss

After 16 weeks, it outperformed semaglutide for weight loss, producing an 8.7% reduction in body weight compared to 5.3%.

It works in two ways at once: reducing how much food energy you take in and increasing how much energy your body burns.

At the 4.8mg dose, people lost an average of 14.9% of their body weight after 46 weeks, and 55% of them lost 15% or more.

metabolic

63-67% of people reduced their liver fat by 30% or more.

At the highest doses, it lowered long-term blood sugar levels (HbA1c) by up to 1.6%.

At the 4.8mg dose, 62% of people saw their fatty liver disease (MASH) improve without their liver scarring getting any worse.

What Are the Side Effects of Survodutide?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Not recommended in pregnancy or breastfeeding

Use contraception during treatment

Stop Right Away If You Notice

Severe persistent nausea/vomiting preventing oral intake

Signs of pancreatitis (severe abdominal pain radiating to back)

Allergic reactions (rash, itching, difficulty breathing)

Severe hypoglycemia with insulin/sulfonylureas

Gallbladder symptoms (right upper quadrant pain)

Significant tachycardia or arrhythmias

Milder Signs to Watch For

Cloudy solution or visible particles indicates contaminationDiscoloration of powder or solution
Was it helpful?Yes
No

How Long Should a Survodutide Cycle Last?

This breaks down how long a typical Survodutide cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Week 1-4
Possible nausea, reduced appetite (most common during escalation)
Week 4-8
Initial weight loss begins; improved satiety between meals
Week 8-16
Progressive weight loss; potential energy level improvements
Week 16-24
Approaching steady-state; more consistent effects
Week 0-0
Sustained weight loss; average 15-19% by week 46

Cheat Sheets Featuring Survodutide

See how Survodutide fits into a broader research stack with these free downloadable cheat sheets. Each one includes reference dose ranges, dosing frequency, and half-life for every peptide it covers. For research purposes only.

View all
Master Peptide Cheat Sheet
Master Peptide Cheat Sheet

78 peptides

Metabolic Peptide Cheat Sheet
Metabolic Peptide Cheat Sheet

14 peptides

Weight Loss Peptide Cheat Sheet
Weight Loss Peptide Cheat Sheet

19 peptides

Survodutide Research References

It is a phase 3 compound

3Research references

Survodutide

Survodutide is a phase 3 compound

Phase 2 MASH and Fibrosis Trial

293 participants with biopsy-confirmed MASH; 48 weeks. MASH improvement: 62% (4.8mg) vs 14% placebo; 63-67% achieved ≥30% liver fat reduction.

2024

Phase 2 Type 2 Diabetes Trial

Head-to-head vs semaglutide 1.0mg; 16 weeks. Survodutide -8.7% weight loss vs semaglutide -5.3%; HbA1c reduction up to -1.6%.

2023

Phase 2 Obesity Trial Without Diabetes

387 participants; BMI ≥27 kg/m²; 46 weeks. 14.9% mean weight loss at 4.8mg; 83% achieved ≥5%, 69% achieved ≥10%, 55% achieved ≥15%.

2024

Frequently Asked Questions About Survodutide

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.